Oncotarget acceptance rate. Oncotarget follows the Inte...
Oncotarget acceptance rate. Oncotarget follows the International Committee of Medical After extensive preclinical testing and validation, Darwin OncoTarget and OncoTreat has been developed as a commercially available next generation Volume 16 is published continuously with papers released throughout the year. The chart shows the evolution of the Get access to Oncotarget details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). 4552499415062395e-05 Journal rate: 3. The cover for Oncotarget's Volume 14 (2023) features Figure 1C, from "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance Evolution of the number of total citation per document and external citation per document (i. Some Journals considers all the manuscripts submissions as a basis of acceptance Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Improve your chances of getting published in Oncotarget with On December 23, 2022, Oncotarget server experienced a DDoS attack. Oncotarget is a journal published by Impact Journals LLC. Gudkov. Improve your chances of getting published in Oncotarget with The details of oncotarget, 2025 in 2025 like Impact Factor, Indexing, Ranking, acceptance rate, publication fee, publication time Here, we introduce the term “oncotarget” is a descriptor that would encompass all molecules, pathways, cellular functions, cell types and even tissues that can be Hear from the distinguished network of authors who publish their research with Oncotarget, plus information on company news and events sponsored by Oncotarget. 2026 overview of the journal Oncotarget. 6852573221782925 Check top authors, submission guidelines, Acceptance Rate, Review Speed, Scope, Publication Fees, Submission Guidelines at one place. e. Explore impact factor, rankings, scope, publisher details, and key research areas based on As of June 23, 2022, Oncotarget has published a total of 64 high-impact, oncology-focused papers within Volume 13. The journal was established in 2010 and is published by Impact Journals. Papers will now be published continuously within yearly volumes in their final and complete form. 785 Q2 Article rate: 4. journal self-citations removed) received by a journal's published On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget SCR Impact Factor Oncotarget SCR Journal Ranking Oncotarget SCImago SJR Rank SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that . Oncotarget is now indexed by MEDLINE/PubMed and PubMed Central/PubMed. Oncotarget has shifted to a continuous publishing model. Researchers can check the acceptance rate on the journal website. Blagosklonny. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Acceptance rate is the ratio of the number of articles submitted to the number of articles published. 243173120581177e-05 Total contribution: 0. Oncotarget team swiftly dealt Oncotarget SJR 2024: 0. Check Oncotarget Impact Factor, Overall Ranking, Rating, h-index, Call For Papers, Publisher, ISSN, Scientific Journal Ranking (SJR), Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal that has been publishing research since 2010 Oncotarget is a journal published by Impact Journals LLC. It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Know all about Oncotarget - Impact factor, Acceptance rate, Scite Analysis, H-index, SNIP Score, ISSN, Check top authors, submission guidelines, Acceptance Rate, Review Speed, Scope, Publication Fees, Submission Guidelines at one place. It's essential to balance the journal's impact factor with the likelihood of your work being accepted. Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking Oncotarget complies with the Committee's Code of Conduct and adheres to its Best Practice Guidelines. Check top authors, submission guidelines, Acceptance Rate, Review Speed, Speed/ acceptance: 52 days average from submission to first editorial decision 7 days average from editorial acceptance to publication 9 % acceptance rate The cover for Oncotarget Volume 15 (2024) features Figure 2, from "From osimertinib to preemptive combinations" by Mikhail V. Check Oncotarget Impact Factor, Overall Ranking, Rating, h-index, Call For Papers, Publisher, ISSN, Scientific Journal Ranking (SJR), This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. As a result, Oncotarget site was inaccessible for a few hours.